Relationship between patient age and duration of physician visit in ambulatory setting: Does one size fit all?

Journal of the American Geriatrics Society

Volumn 53, Issue 7, 2005, Pages 1162-1167

  Lo, Agnes ^a,c   Ryder, Kathryn ^a   Shorr, Ronald I ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Methodist Health System   (United States)

^c NONE   (United States)

Author keywords

Ambulatory care; Comorbid illness; Duration of visit; Elderly; Medications

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; LEVOTHYROXINE; NARCOTIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SEDATIVE AGENT; THYROXINE; WARFARIN;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CEREBROVASCULAR DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOCTOR PATIENT RELATION; DRUG MONITORING; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MEDICAL FEE; PATIENT COUNSELING; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; TRANSIENT ISCHEMIC ATTACK; AGE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIAGNOSIS; MIDDLE AGED; STATISTICS; TIME; UNITED STATES; UTILIZATION REVIEW;

AGE FACTORS; AGED; AMBULATORY CARE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; PRESCRIPTIONS, DRUG; TIME FACTORS; UNITED STATES;

EID: 24344484343     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2005.53367.x     Document Type: Article

References (24)

1. Blumenthal D, Causino N, Chang YC et al. The duration of ambulatory visits to physicians. J Fam Pract 1999;48:264-271.
2. Mechanic D, McAlpine DD, Rosenthal M. Are patients' office visits with physicians getting shorter? N Engl J Med 2001;344:198-204.
3. Smith DM, Martin DK, Langefeld CD et al. Primary care physician productivity: The physician factor. J Gen Intern Med 1995;10:495-503.
4. Hu P, Reuben DB. Effects of managed care on the length of time that elderly patients spend with physicians during ambulatory visits. The National Ambulatory Medical Care Survey. Med Care 2002;40:606-613.
5. Nowalk MP, Bardella IJ, Zimmerman RK et al. The physician's office: Can it influence adult immunization rates? Am J Manag Care 2004;10:13-19.
6. Streja DA, Rabkin SW. Factors associated with implementation of preventative care measures in patients with diabetes mellitus. Arch Intern Med 1999;159:294-302.
7. Tamblyn R, Berkson L, Dauphinee WD et al. Unnecessary prescribing of NSAIDS and the management of NSAID-related gastropathy in medical practices. Ann Intern Med 1997;127:429-438.
8. Gurwitz JH, Field TS, Harrold LR et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-1116.
9. Aparasu RR, Fliginger SE. Inappropriate medication prescribing for the elderly by office-based physicians. Ann Pharmacother 1997;31:823-829.
10. Gandhi TK, Weingart SN, Borus J et al. Adverse drug events in ambulatory care. N Engl J Med 2003;348:1556-1564.
11. Chang CM, Liu PY, Yang YH et al. Potentially inappropriate drug prescribing among first-visit elderly outpatients in Taiwan. Pharmacotherapy 2004; 24:848-855.
12. Cherry DK, Burt CW, Woodwell DA. National Ambulatory Medical Care Survey: 2001 summary. Adv Data 2003;337:1-44.
13. Higashi T, Shekelle PG, Solomon DH et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 2004;140:714-720.
14. Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 2004;164:305-312.
15. Hohl CM, Dankoff J, Colacone A et al. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001;38:666-671.
16. Hanlon JT, Schmader KE, Koronkowski MJ et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997;45:945-948.
17. Fick D, Cooper J, Wade WE et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a U.S. consensus panel of experts. Arch Intern Med 2003;163:2716-2724.
18. Rohrer JE, Xu KT, Bickley L. Duration of heart disease visits by elderly patients: Productivity versus quality. Health Serv Manage Res 2002;15:141-146.
19. Sloane PD. Changes in ambulatory care with patient age: Is geriatric care qualitatively different? Fam Med 1991;23:40-43.
20. Barton LL. Changes in the length of office visits. N Engl J Med 2001;344: 1476.
21. Simmons ED. Changes in the length of office visits. N Engl J Med 2001; 344:1476.
22. Campion EW. A symptom of discontent. N Engl J Med 2001;344:223-225.
23. Azad N, Tierney M, Victor G et al. Adverse drug events in the elderly population admitted to a tertiary care hospital. J Health Manage 2002;47: 295-305.
24. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991;114:956-966.